Angiogenic properties of dehydrated human amnion/chorion allografts: therapeutic potential for soft tissue repair and regeneration
Open Access
- 1 January 2014
- journal article
- Published by Publiverse Online S.R.L in Vascular Cell
- Vol. 6 (1), 10
- https://doi.org/10.1186/2045-824x-6-10
Abstract
Chronic wounds are associated with a number of deficiencies in critical wound healing processes, including growth factor signaling and neovascularization. Human-derived placental tissues are rich in regenerative cytokines and have been shown in randomized clinical trials to be effective for healing chronic wounds. In this study, PURION® Processed (MiMedx Group, Marietta, GA) dehydrated human amnion/chorion membrane tissue allografts (dHACM, EpiFix®, MiMedx) were evaluated for properties to support wound angiogenesis. Angiogenic growth factors were identified in dHACM tissues using enzyme-linked immunosorbent assays (ELISAs), and the effects of dHACM extract on human microvascular endothelial cell (HMVEC) proliferation and production of angiogenic growth factors was determined in vitro. Chemotactic migration of human umbilical vein endothelial cells (HUVECs) toward pieces of dHACM tissue was determined using a standard in vitro transwell assay. Neovascularization of dHACM in vivo was determined utilizing a murine subcutaneous implant model. Quantifiable levels of the angiogenic cytokines angiogenin, angiopoietin-2 (ANG-2), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), heparin binding epidermal growth factor (HB-EGF), hepatocyte growth factor (HGF), platelet derived growth factor BB (PDGF-BB), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) were measured in dHACM. Soluble cues promoted HMVEC proliferation in vitro and increased endogenous production of over 30 angiogenic factors by HMVECs, including granulocyte macrophage colony-stimulating factor (GM-CSF), angiogenin, transforming growth factor β3 (TGF-β3), and HB-EGF. 6.0 mm disks of dHACM tissue were also found to recruit migration of HUVECs in vitro. Moreover, subcutaneous dHACM implants displayed a steady increase in microvessels over a period of 4 weeks, indicative of a dynamic intra-implant neovascular process. Taken together, these results demonstrate that dHACM grafts: 1) contain angiogenic growth factors retaining biological activity; 2) promote amplification of angiogenic cues by inducing endothelial cell proliferation and migration and by upregulating production of endogenous angiogenic growth factors by endothelial cells; and 3) support the formation of blood vessels in vivo. dHACM grafts are a promising wound care therapy with the potential to promote revascularization and tissue healing within poorly vascularized, non-healing wounds.Keywords
This publication has 31 references indexed in Scilit:
- A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcersInternational Wound Journal, 2013
- The effects of different preservation processes on the total protein and growth factor content in a new biological product developed from human amniotic membraneCell and Tissue Banking, 2011
- Donor age and gestational age influence on growth factor levels in human amniotic membraneActa Ophthalmologica, 2010
- Amnion-Derived Cellular Cytokine Solution (ACCS) Promotes Migration of Keratinocytes and FibroblastsAnnals of Plastic Surgery, 2010
- The molecular biology of chronic wounds and delayed healing in diabetesDiabetic Medicine, 2006
- Angiogenesis, Vasculogenesis, and Induction of Healing in Chronic WoundsVascular and Endovascular Surgery, 2005
- Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reactionClinical and Experimental Immunology, 2002
- Growth factor mRNA and protein in preserved human amniotic membraneCurrent Eye Research, 2000
- Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind studyDiabetes Care, 1998
- TREATMENT OF CHRONIC ULCERATION OF THE LEGS WITH HUMAN AMNIONThe Lancet, 1980